Breakthrough Genomics’ ability to deliver “better results faster” for a wide-range of genetics tests is the result of the company’s proprietary techniques for the clinical interpretation of genomic data.
The revolutionary methodology employed by the Breakthrough Genomics’ team leverages intelligent bioinformatic architecture that is able to simultaneously analyze millions of up-to-date scientific publications and terabytes of clinical genomic data.
The result is the ability to accurately pinpoint pathogenic and likely pathogenic genetic variants within minutes.
Each test result is then individually reviewed by a board-certified medical geneticist.
Depending in the genetic test being analyzed the Breakthrough Genomics team uses one of two proprietary AI-powered diagnostic platform: